Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol Sedation in Obese Patients for GI Endoscopy
NCT05517408Unknown
- Sponsor
- Renji Hospital
- Start
- Sep 2022
- Primary completion
- Nov 2022
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Open-label, single-arm trial of ciprofol in Procedural sedation (PS), sponsored by Renji Hospital. Primary endpoint: Median effective dose at 2 hours. Status: unknown.
02
Drugs
ciprofol
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT05517408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05517408.